Kazuya Okushin

9PUBLICATIONS
28CO-AUTHORS
Disease surveillanceNaturopathySport and exercise nutritionClinical nutritionCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 06, 2026
Real-World Effectiveness of Tolvaptan for Hyponatremia in Cirrhosis Across Global Regions: A Target Trial Emulation.

Kazuya Okushin, Ryosuke Tateishi, Mitsuhiro Fujishiro

|Dec 29, 2025
Cachexia in Cirrhosis Is Characterized by Sex-Specific Loss of Muscle Mass and Adipose Tissue.

Takao Miwa, Goki Suda, Ryosuke Tateishi

|Jul 12, 2025
Cachexia and Type 2 Diabetes Mellitus Are Independent Factors for Mortality in Patients With Cirrhosis.

Takao Miwa, Goki Suda, Ryosuke Tateishi

|May 03, 2025
Cachexia is an independent predictor of mortality in patients with cirrhosis.

Takao Miwa, Goki Suda, Ryosuke Tateishi

|May 03, 2025
Comparable outcomes among etiologies in early-stage hepatocellular carcinoma: Analysis of a nationwide registry in Japan.

Kazuya Okushin, Ryosuke Tateishi, Shinya Hirakawa

Pageof 2